We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bausch Health Cos | NYSE:VRX | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 23.40 | 0.00 | 01:00:00 |
LAVAL, Quebec, Jan. 30, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it plans to hold a conference call and live webcast on Tuesday, February 28, 2017 at 8:00 a.m. ET. The Company will discuss fourth quarter and full year 2016 financial results, and announce 2017 guidance during the presentation. Related materials will be made available on the investor relations portion of the corporate website before the start of the conference call.
Conference Call Details
Date |
Tuesday, February 28, 2017 |
Time |
8:00 a.m. ET |
Webcast |
http://ir.valeant.com/events-and-presentations |
Participant Event Dial-in |
(877) 876-8393 (North America) |
(443) 961-0178 (International) | |
Participant Passcode |
63999208 |
Replay Dial-in |
(855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode |
63999208 (replay available until 03/31/2017) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-to-hold-conference-call-to-present-fourth-quarter-and-full-year-2016-results-and-announce-2017-guidance-300398963.html
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright 2017 Canada NewsWire
1 Year Valeant Pharma Chart |
1 Month Valeant Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions